Bayer (OTCMKTS:BAYRY) Upgraded by ValuEngine to “Hold”

ValuEngine upgraded shares of Bayer (OTCMKTS:BAYRY) from a sell rating to a hold rating in a research report report published on Thursday, ValuEngine reports.

BAYRY traded down $0.31 during trading on Thursday, hitting $16.24. 437,173 shares of the stock were exchanged, compared to its average volume of 785,821. The company has a market cap of $60.58 billion, a price-to-earnings ratio of 9.28, a P/E/G ratio of 0.78 and a beta of 1.10. Bayer has a 1-year low of $14.61 and a 1-year high of $28.02. The company’s fifty day simple moving average is $16.44. The company has a quick ratio of 0.92, a current ratio of 1.37 and a debt-to-equity ratio of 0.79.

About Bayer

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

Recommended Story: How is inflation measured?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Bayer (OTCMKTS:BAYRY)

Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.